Dajani et al correlated the findings in coronary arteries by echocardiography in patients with Kawasaki Disease with prognostic risk groups. These can help identify patients who may benefit from closer monitoring and more aggressive management. The authors are from the American Heart Association.
Changes in the Coronary Arteries |
Risk Group |
---|---|
no changes at any stage of the disease |
I |
transient ectasia that disappears during the acute illness |
II |
single small to medium aneurysm |
III |
multiple small to medium aneurysms without obstruction |
IV |
one or more giant coronary artery aneurysms |
IV |
obstruction in one or more coronary arteries |
V |
Risk Group |
Pharmacologic Therapy |
Restrictions on Physical Activity |
---|---|---|
I |
none after first 6-8 weeks |
none after first 6-8 weeks |
II |
none after first 6-8 weeks |
none after first 6-8 weeks |
III |
aspirin therapy until abnormalities resolve; may be continued longer in some patients |
age dependent |
IV |
long-term aspirin therapy, consider warfarin |
age dependent |
V |
long term aspirin therapy, consider warfarin; consider use of calcium channel blockers |
most strenuous exercise; physical activity guided by cardiac studies |
where:
• Aspirin therapy is 3 to 5 mg per kg per day.
• For patients in first decade and in Risk Group III or IV, no restrictions in physical activity are needed after the initial 8 weeks.
• For a patient in the second decade or older and in Risk Group III, competitive contact sports with endurance training are discouraged. Physical activity should be guided by the results of stress testing.
• For a patient in the second decade or older and in Risk Group IV, strenuous activities are discouraged. If no ischemia is found on cardiac studies then noncontact recreational sports can be allowed.
Risk Group |
Follow-up |
Invasive Testing |
---|---|---|
I |
none after first year unless cardiac disease suspected |
none |
II |
for first year; consider seeing patient every 3 to 5 years |
none |
III |
annual with ECG and echocardiography; stress testing every other year if active |
angiography if arterial stenosis suspected |
IV |
annual with ECG, chest X-ray and echocardiography; consider pharmacologic stress test for patient in first decade |
angiography if arterial stenosis suspected; elective catheterization may be indicated in selected patients |
V |
ECG and echocardiography every 6 months; annual Holter monitor; annual stress test |
angiography to select therapy or with no or worsening ischemia |
Purpose: To evaluate the coronary arteries of a patient with Kawasaki disease using echocardiography as reported by Dajani et al.
Specialty: Infectious Diseases, Pedatrics
Objective: risk factors, severity, prognosis, stage
ICD-10: M30.3,